0001209191-23-004872.txt : 20230125 0001209191-23-004872.hdr.sgml : 20230125 20230125175028 ACCESSION NUMBER: 0001209191-23-004872 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230123 FILED AS OF DATE: 20230125 DATE AS OF CHANGE: 20230125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jaen Juan C. CENTRAL INDEX KEY: 0001422996 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38419 FILM NUMBER: 23553384 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcus Biosciences, Inc. CENTRAL INDEX KEY: 0001724521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473898435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 694-6200 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-23 0 0001724521 Arcus Biosciences, Inc. RCUS 0001422996 Jaen Juan C. C/O ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY HAYWARD CA 94545 1 1 0 0 President Common Stock 2023-01-23 4 A 0 45800 0.00 A 324682 D Common Stock 1222240 I By Trust Stock Option (right to buy) 22.02 2023-01-23 4 A 0 185900 0.00 A 2033-01-22 Common Stock 185900 185900 D Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company. The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company. /s/ Carolyn Tang, Attorney-in-Fact 2023-01-25